InvestorsHub Logo
Followers 29
Posts 940
Boards Moderated 0
Alias Born 03/10/2014

Re: Rollgard1 post# 3154

Friday, 08/27/2021 8:42:32 AM

Friday, August 27, 2021 8:42:32 AM

Post# of 4271
Morning Roll,

I can agree that there are several things the Company doesn't have control over such as PDFUA dates and whether or not the FDA approves or denies new drugs.

...but not communicating is truly a company problem.

ADMP knows when they are going to meet or miss reported milestones. specifically dates that they release. What they do need to do is provide guidance and support to shareholders that they have valid reasons for hold ups.(Which may/may not be within their control).

Trials can be completed with the 45M they raised in the last offering. Grant monies for said trials will still be paid as long as they are properly applied for.

Did the company say anything about the 7.9M they paid to Nephron on May 13th after three years in court?

Did they say anything about having to refile quarterly's for the past year because the "Misapplication of valuation principals" in regards to warrants issued to purchase stock?

Have they provided any info to shareholder in regards to how they plan to regain compliance? Or have they told shareholders that they have provided the SEC a plan to regain compliance?


Yes...I am a long, but I am frustrated with the company's lack of communication!

They were great at communicating how important it was to save their butts on the re-election, but not so good at communicating anything else.

In My Own Personal Opinion Of Course!